OpenAlex
PricingAboutJobs
Log inGet started
Work

A phase 1/2A Trial of STA 5326, an oral interleukin-12/23 inhibitor, in patients with active moderate to severe Crohnʼs disease

HTML

Year: 2006
Type: article
Study design: Clinical Trial
Source: Inflammatory Bowel Diseases
DOI: 10.1097/01.ibd.0000225337.14356.31
Authors: Robert Burakoff, Charles F. Barish, Dennis Riff, Ronald Pruitt, William Y. Chey, Francis A. Farraye, Ira Shafran, Seymour Katz, Charles L. Krone, Martha Vander Vliet, Christopher Stevens, Matthew L. Sherman, Eric Jacobson, Ronald Bleday
Institutions: Brigham and Women's Hospital, Wake Research, Tennessee Clinical Research Center, Boston Medical Center, Shafran Gastroenterology Center, Synta Pharmaceuticals (United States)
Language: English

Topic: Inflammatory Bowel Disease
Subfield: Gastroenterology
Field: Medicine
Domain: Health Sciences
Keyword: IL-12/23 inhibitors
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2167451347
FWCI: 6.81
Cites: 26
Cited by: 117
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security